RBRK Fundamental Analysis - RUBRIK INC-A

Fundamental Rating

Overall RBRK gets a fundamental rating of 3 out of 10. We evaluated RBRK against 278 industry peers in the Software industry. RBRK may be in some trouble as it scores bad on both profitability and health. RBRK is valued quite expensive, but it does show an excellent growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year RBRK has reported negative net income.

In the past year RBRK had a positive cash flow from operations.

1.2 Ratios

RBRK has a Return On Assets of -14.78%. This is in the lower half of the industry: RBRK underperforms 69.78% of its industry peers.

		Industry Rank	Sector Rank
ROA	-14.78%
ROE	N/A
ROIC	N/A

ROA(3y)-52.6%

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 79.05%, RBRK is in the better half of the industry, outperforming 77.34% of the companies in the same industry.

RBRK's Gross Margin has been stable in the last couple of years.

The Profit Margin and Operating Margin are not available for RBRK so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	79.05%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.12%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

RBRK does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, RBRK has more shares outstanding

RBRK has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.74, we must say that RBRK is in the distress zone and has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of 1.74, RBRK is in line with its industry, outperforming 45.32% of the companies in the same industry.

RBRK has a debt to FCF ratio of 4.65. This is a neutral value as RBRK would need 4.65 years to pay back of all of its debts.

RBRK has a Debt to FCF ratio of 4.65. This is comparable to the rest of the industry: RBRK outperforms 58.27% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	4.65
Altman-Z	1.74

ROIC/WACCN/A

WACC10.96%

2.3 Liquidity

RBRK has a Current Ratio of 1.78. This is a normal value and indicates that RBRK is financially healthy and should not expect problems in meeting its short term obligations.

Looking at the Current ratio, with a value of 1.78, RBRK is in line with its industry, outperforming 53.96% of the companies in the same industry.

RBRK has a Quick Ratio of 1.77. This is a normal value and indicates that RBRK is financially healthy and should not expect problems in meeting its short term obligations.

With a Quick ratio value of 1.77, RBRK perfoms like the industry average, outperforming 54.32% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.78
Quick Ratio	1.77

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 69.41% over the past year.

RBRK shows a strong growth in Revenue. In the last year, the Revenue has grown by 48.93%.

Measured over the past years, RBRK shows a very strong growth in Revenue. The Revenue has been growing by 20.54% on average per year.

EPS 1Y (TTM)69.41%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%147.62%

Revenue 1Y (TTM)48.93%

Revenue growth 3Y20.54%

Revenue growth 5YN/A

Sales Q2Q%48.26%

3.2 Future

The Earnings Per Share is expected to grow by 21.85% on average over the next years. This is a very strong growth

RBRK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.88% yearly.

EPS Next Y79.03%

EPS Next 2Y40.17%

EPS Next 3Y30.8%

EPS Next 5Y21.85%

Revenue Next Year42.93%

Revenue Next 2Y33.54%

Revenue Next 3Y30.43%

Revenue Next 5Y24.88%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

RBRK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year RBRK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

RBRK's Price/Free Cash Flow is on the same level as the industry average.

		Industry Rank	Sector Rank
P/FCF	63.93
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as RBRK's earnings are expected to grow with 30.80% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y40.17%

EPS Next 3Y30.8%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

RBRK does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

RUBRIK INC-A

NYSE:RBRK (12/26/2025, 8:12:21 PM)

After market: 78.38 -0.28 (-0.36%)

78.66

-0.14 (-0.18%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustrySoftware

Earnings (Last)12-04 2025-12-04/amc

Earnings (Next)03-13 2026-03-13

Inst Owners75.97%

Inst Owner Change5.23%

Ins Owners2.46%

Ins Owner Change24.41%

Market Cap15.53B

Revenue(TTM)1.20B

Net Income(TTM)-376.75M

Analysts82.76

Price Target116.68 (48.33%)

Short Float %8.26%

Short Ratio3.66

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)124.58%

Min EPS beat(2)91.34%

Max EPS beat(2)157.81%

EPS beat(4)4

Avg EPS beat(4)89.37%

Min EPS beat(4)53.87%

Max EPS beat(4)157.81%

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)2

Avg Revenue beat(2)7.54%

Min Revenue beat(2)7.43%

Max Revenue beat(2)7.64%

Revenue beat(4)4

Avg Revenue beat(4)7.12%

Min Revenue beat(4)4.87%

Max Revenue beat(4)8.55%

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-1.5%

PT rev (3m)-1.1%

EPS NQ rev (1m)13.35%

EPS NQ rev (3m)17.34%

EPS NY rev (1m)-0.17%

EPS NY rev (3m)50.42%

Revenue NQ rev (1m)5.41%

Revenue NQ rev (3m)4.84%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0.24%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	12.98
P/FCF	63.93
P/OCF	56.8
P/B	N/A
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-0.26

EYN/A

EPS(NY)-0.08

Fwd EYN/A

FCF(TTM)1.23

FCFY1.56%

OCF(TTM)1.38

OCFY1.76%

SpS6.06

BVpS-2.66

TBVpS-3.67

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-14.78%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	79.05%
FCFM	20.3%

ROA(3y)-52.6%

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.12%

GM growth 5YN/A

F-Score5

Asset Turnover0.47

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	4.65
Debt/EBITDA	N/A
Cap/Depr	90.35%
Cap/Sales	2.55%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.78
Quick Ratio	1.77
Altman-Z	1.74

F-Score5

WACC10.96%

ROIC/WACCN/A

Cap/Depr(3y)109.27%

Cap/Depr(5y)N/A

Cap/Sales(3y)3.97%

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)69.41%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%147.62%

EPS Next Y79.03%

EPS Next 2Y40.17%

EPS Next 3Y30.8%

EPS Next 5Y21.85%

Revenue 1Y (TTM)48.93%

Revenue growth 3Y20.54%

Revenue growth 5YN/A

Sales Q2Q%48.26%

Revenue Next Year42.93%

Revenue Next 2Y33.54%

Revenue Next 3Y30.43%

Revenue Next 5Y24.88%

EBIT growth 1Y65.56%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year69.98%

EBIT Next 3Y36.02%

EBIT Next 5YN/A

FCF growth 1Y188.19%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y1167.46%

OCF growth 3YN/A

OCF growth 5YN/A

RUBRIK INC-A / RBRK FAQ

Can you provide the ChartMill fundamental rating for RUBRIK INC-A?

ChartMill assigns a fundamental rating of 3 / 10 to RBRK.

What is the valuation status for RBRK stock?

ChartMill assigns a valuation rating of 1 / 10 to RUBRIK INC-A (RBRK). This can be considered as Overvalued.

What is the profitability of RBRK stock?

RUBRIK INC-A (RBRK) has a profitability rating of 1 / 10.

How financially healthy is RUBRIK INC-A?

The financial health rating of RUBRIK INC-A (RBRK) is 3 / 10.

RUBRIK INC-A (RBRK) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

RUBRIK INC-A / RBRK FAQ

Can you provide the ChartMill fundamental rating for RUBRIK INC-A?

What is the valuation status for RBRK stock?

What is the profitability of RBRK stock?

How financially healthy is RUBRIK INC-A?